10 Alarming Predictions for Deep Learning in 2018
The incredible breakthroughs we saw in 2017 for Deep Learning is going to carry over in a very powerful way in 2018. A lot of work coming from research will be migrating itself into everyday software applications.
Ten Predictions For AI Silicon In 2018
2017 was an exciting year for fans and adopters of AI. As we enter 2018, I wanted to take a look at what lies ahead. One thing is certain: we’ve barely just begun on this journey and there will be great successes and monumental failures in the year to come. Before I dive into the dangerous waters of predictions, it might be helpful to set the stage with some of the highlights and lowlights of AI of 2017. A lot happened this past year so I will try to keep this brief!
2017 in Review: 10 AI Failures
"At Synced we are naturally fans of machine intelligence, but we also realize some new techniques struggle to perform their tasks effectively, often blundering in ways that humans would not."
Highlights From NIPS 2017 And What It Means For Your AI Education
This post targets engineers, AI scientists and the technical audience and aims to give an overview about observed AI and ML trends at NIPS 2017.
With all new technologies there are predictions of how good it will be for humankind, or how bad it will be. A common thread that I have observed is how people tend to underestimate how long new technologies will take to be adopted after proof of concept demonstrations. I pointed to this as the seventh of seven deadly sins of predicting the future of AI.
Deep Learning Sharpens Views of Cells and Genes
Neural networks are making biological images easier to process
Fair and Balanced? Thoughts on Bias in Probabilistic Modeling
In recent months and years, the Machine Learning community has conducting a notable amount of soul searching on the question of algorithmic bias: are our algorithms operating in ways that are fundamentally unfair towards specific groups within society?
Investments in AI for drug discovery are surging. Big Pharmas are throwing big bucks. Sanofi signed a 300 Million dollars deal with the startup Exscientia, and GSK did the same for 42 Million dollars. The Silicon Valley VC firm Andreessen Horowitz launched a new 450 Million dollars bio investment fund, with one focus area in applications of AI to drug discovery. In this craze, lots of pharma/biotech companies and investors wonder whether they should jump on the bandwagon in 2018, or wait and see.
Building AI systems that work is still hard
Even with the support of AI frameworks like TensorFlow or OpenAI, artificial intelligence still requires deep knowledge and understanding compared to a mainstream web developer. If you have built a working prototype, you are probably the smartest guy in the room. Congratulations, you are a member of a very exclusive club.
The Robots Are Coming, and Sweden Is Fine
In a world full of anxiety about the potential job-destroying rise of automation, Sweden is well placed to embrace technology while limiting human costs.